Centro de Biología Molecular & Farmacogenética, Departamento de Ciencias Básicas, Facultad de Medicina, Universidad de La Frontera, Temuco, Chile.
Departamento de Odontología Adultos, Facultad de Odontología, Universidad de La Frontera, Temuco, Chile.
Oral Dis. 2018 Sep;24(6):1132-1139. doi: 10.1111/odi.12856. Epub 2018 Jun 7.
The aim of this study was to compare the global DNA methylation levels in patients under bruxism treatment and a control group.
Subjects undergoing bruxism treatment were classified in awake bruxism (42 patients), sleep bruxism (32 patients) and both conditions (42 patients). The control group included 42 individuals. A colorimetric assay (MethylFlash Methylated DNA 5-mC Quantification Kit, Epigenetic Group Inc., NY, USA) was used to determine the global DNA methylation levels.
Statistically significant differences were found in amounts of methylated DNA in all circadian manifestations of bruxism compared with a control group (sleep bruxism = 0.95% ± 2.02%; awake bruxism = 0.87% ± 2.1%; sleep and awake bruxism = 0.17% ± 0.25%; Control = 1.69% ± 1.6%; Kruskal-Wallis test [p = .0001] followed by Dunn's test [p < .05]).
Patients undergoing bruxism treatment exhibited hypomethylated DNA levels when compared to control group. Our results suggest that DNA hypomethylation might be a novel aetiologic factor in bruxism aetiology. Further researches must be performed exploring the role of epigenetics modifications in circadian manifestations of bruxism.
本研究旨在比较磨牙症治疗患者和对照组的全基因组 DNA 甲基化水平。
将磨牙症治疗患者分为觉醒性磨牙症(42 例)、睡眠性磨牙症(32 例)和两种情况同时存在(42 例)。对照组包括 42 名个体。采用比色法(MethylFlash Methylated DNA 5-mC Quantification Kit,Epigenetic Group Inc.,NY,USA)测定全基因组 DNA 甲基化水平。
与对照组相比,所有磨牙症昼夜节律表现中甲基化 DNA 含量均存在统计学差异(睡眠性磨牙症=0.95%±2.02%;觉醒性磨牙症=0.87%±2.1%;睡眠和觉醒性磨牙症=0.17%±0.25%;对照组=1.69%±1.6%;Kruskal-Wallis 检验[P=0.0001],随后 Dunn 检验[P<0.05])。
与对照组相比,磨牙症治疗患者的 DNA 呈低甲基化状态。我们的研究结果表明,DNA 低甲基化可能是磨牙症发病机制的一个新的病因因素。必须进一步研究探索表观遗传学修饰在磨牙症昼夜节律表现中的作用。